key insights: biosimilars and novel targets in ibd
Published 5 years ago • 142 plays • Length 20:34Download video MP4
Download video MP3
Similar videos
-
21:40
key insights in ibd: mastering clinical challenges & emerging therapies 2018
-
24:37
key insights: novel targets for ibd therapy - is this the final frontier?
-
17:16
key insights: mastering clinical challenges and emerging therapies in ibd
-
21:27
key insights: great debates and updates in ibd 2018
-
16:44
the current landscape of biosimilars in ibd
-
23:19
key insights in ibd: 2017 mastering clinical challenges & emerging therapies
-
17:27
key insights: pediatric ibd
-
21:14
when and how to use immunomodulators and biologics in ibd
-
4:04
biosimilars and inflammatory bowel disease
-
11:40
debate: biosimilar therapies - caution, more studies are needed
-
8:07
biosimilars | what is a biosimilar? | gastrointestinal society
-
18:23
biosimilars for ibd: to start, switch, or stay away?
-
13:19
what are biosimilar therapies and why should we care?
-
23:44
mechanisms of disease: biologic pipeline for ibd
-
3:52
the immune response and ibd
-
5:03
overview of novel therapeutic approaches to ibd
-
1:21
biosimilars: terms to know